VINCI PHARMACEUTICALS

Serial Number 98066500
732

Registration Progress

Application Filed
Jun 30, 2023
Under Examination
Feb 13, 2024
Approved for Publication
Dec 19, 2023
Published for Opposition
Dec 19, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Feb 13, 2026 179 days

Trademark Image

VINCI PHARMACEUTICALS

Basic Information

Serial Number
98066500
Filing Date
June 30, 2023
Published for Opposition
December 19, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
May 22, 2025
Application
Pending
Classes
005 042

Rights Holder

Vinci Pharmaceuticals, Inc.

03
Address
12 Washington Ave.
Avon by the Sea, NJ 07717

Ownership History

Vinci Pharmaceuticals, Inc.

Original Applicant
03
Avon by the Sea, NJ

Vinci Pharmaceuticals, Inc.

Owner at Publication
03
Avon by the Sea, NJ

Legal Representation

Attorney
Susan Neuberger Weller

USPTO Deadlines

Next Deadline
179 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
February 13, 2026
Extension Available
Until February 13, 2025

Application History

27 events
Date Code Type Description Documents
May 23, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 22, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 22, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 22, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 13, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 13, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 13, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 19, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 19, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 13, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 19, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 19, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 29, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 13, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 13, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 13, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 13, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 13, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 13, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 6, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 4, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of retinal diseases
Class 042
research and development services in the field of retinal diseases; conducting clinical trials for others in the field of retinal diseases

Additional Information

Translation
The English translation of "VINCI" in the mark is "win".

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"